Florida Gastroenterological Society
Florida Gastroenterological Society
Monthly Archives: December 2019

7 Recent reports in IBD

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research on inflammatory bowel diseaseThese reports includeREAD MORE ›

Posted in News

Treat-to-target measured by ultrasonography linked with better Crohn’s outcomes

Small intestine contrast ultrasonographic assessment of mucosal healing can be an effective method to gauge response to anti-TNF therapy amongREAD MORE ›

Posted in News

FDA approves maintenance olaparib for BRCA-mutated metastatic pancreatic cancer

The FDA approved olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic cancer, accordingREAD MORE ›

Posted in News

Inpatient opioids linked with future opioid use in IBD

Patients with inflammatory bowel disease who received intravenous or non-intravenous opioids while in the hospital are more likely to beREAD MORE ›

Posted in News

Intestinal ultrasound helps monitor response in ulcerative colitis

Assessing bowel wall thickness with intestinal ultrasound can be a helpful tool to monitor therapeutic response in patients with ulcerativeREAD MORE ›

Posted in News

7 recent reports on the esophagus

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research on the esophagus and GERD.These reportsREAD MORE ›

Posted in News

Early colonoscopy does not improve lower GI bleeding outcomes

Moving patients to colonoscopy within 24 hours of hospital admission for acute lower gastrointestinal bleeding does not reduce further bleedingREAD MORE ›

Posted in News

Switch to Entyvio after calcineurin inhibitor induction safe, effective for ulcerative colitis

Transitioning to Entyvio after achieving induction of remission with calcineurin inhibitor therapy is safe and effective for patients with ulcerativeREAD MORE ›

Posted in News

PXL065 proves safe, well-tolerated ahead of phase 2 trial for NASH

Poxel announced positive safety, tolerability and pharmacokinetic results from a phase 1b multiple ascending dose trial of PXL065, a deuterium-stabilizedREAD MORE ›

Posted in News

Anti-TNF alpha not linked with recurrent, new primary cancers in IBD

Patients with inflammatory bowel disease and other immune-mediated diseases treated with anti-TNF alpha who previously had cancer are not atREAD MORE ›

Posted in News

FGS Login Portal

Not Member yet? Register | Forgot password?